| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.1 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.1 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.046 | 0.1 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.074 | 0.1 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |